Top 5 Stocks to Buy Now
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free NKGNW Stock Alerts

NKGen Biotech (NKGNW) Competitors

$0.0003 0.00 (0.00%)
As of 06/18/2026
Compare

NKGNW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy NKGen Biotech stock or one of its competitors? MarketBeat compares NKGen Biotech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NKGen Biotech include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does NKGen Biotech compare to 60 Degrees Pharmaceuticals?

NKGen Biotech (NASDAQ:NKGNW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability.

In the previous week, NKGen Biotech's average media sentiment score of 0.00 equaled 60 Degrees Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
NKGen Biotech Neutral
60 Degrees Pharmaceuticals Neutral

Company Net Margins Return on Equity Return on Assets
NKGen BiotechN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NKGen BiotechN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats NKGen Biotech on 1 of the 1 factors compared between the two stocks.

How does NKGen Biotech compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and NKGen Biotech (NASDAQ:NKGNW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
NKGen Biotech N/A N/A N/A

In the previous week, Alpha Tau Medical's average media sentiment score of 0.00 equaled NKGen Biotech'saverage media sentiment score.

Company Overall Sentiment
Alpha Tau Medical Neutral
NKGen Biotech Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
NKGen BiotechN/AN/AN/AN/AN/A

Summary

Alpha Tau Medical and NKGen Biotech tied by winning 0 of the 0 factors compared between the two stocks.

How does NKGen Biotech compare to Apollomics?

NKGen Biotech (NASDAQ:NKGNW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

In the previous week, NKGen Biotech's average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company Overall Sentiment
NKGen Biotech Neutral
Apollomics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NKGen BiotechN/AN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
NKGen BiotechN/A N/A N/A
Apollomics N/A N/A N/A

Summary

Apollomics beats NKGen Biotech on 1 of the 1 factors compared between the two stocks.

How does NKGen Biotech compare to BioVie?

BioVie (NASDAQ:BIVIW) and NKGen Biotech (NASDAQ:NKGNW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
NKGen BiotechN/AN/AN/AN/AN/A

In the previous week, BioVie's average media sentiment score of 0.00 equaled NKGen Biotech'saverage media sentiment score.

Company Overall Sentiment
BioVie Neutral
NKGen Biotech Neutral

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
NKGen Biotech N/A N/A N/A

Summary

BioVie and NKGen Biotech tied by winning 0 of the 0 factors compared between the two stocks.

How does NKGen Biotech compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and NKGen Biotech (NASDAQ:NKGNW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
NKGen Biotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
NKGen BiotechN/AN/AN/AN/AN/A

In the previous week, Cardio Diagnostics' average media sentiment score of 0.00 equaled NKGen Biotech'saverage media sentiment score.

Company Overall Sentiment
Cardio Diagnostics Neutral
NKGen Biotech Neutral

Summary

Cardio Diagnostics beats NKGen Biotech on 1 of the 1 factors compared between the two stocks.

Get NKGen Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for NKGNW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NKGNW vs. The Competition

Export
MetricNKGen BiotechBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$381.56M$6.43B$12.60B
Dividend YieldN/A3.86%2.68%5.81%
P/E RatioN/A3.1224.7524.44
Price / SalesN/A6,861.77530.00108.87
Price / CashN/A13.1345.0755.09
Price / BookN/A92.2610.806.58
Net IncomeN/A-$96.07M$3.57B$337.17M
7 Day PerformanceN/A0.88%0.72%0.83%
1 Month PerformanceN/A-0.66%0.41%2.25%
1 Year PerformanceN/A54.58%29.34%36.14%

NKGen Biotech Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NKGNW
NKGen Biotech
N/A$0.00
flat		N/AN/A$0.00N/AN/A63
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
-2.6%		N/A-37.3%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$2.06
-1.4%		N/A+730.5%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.02
-8.7%		N/A-26.2%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.31
flat		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NKGNW) was last updated on 6/21/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
A huge SpaceX error just led one stock to 3X move!
SPCE surged roughly 300% in a single week after investors hunting SpaceX exposure piled into the wrong ticker....
InvestPub | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel